Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 01-May-24 8:45 PM View:  | Bioatla, Inc. (BCAB) | 30-Apr-24 | Payment of Exercise | 2,181 | $2.26 | $4,929.06 | (< 1%) 292.45K to 290.27K | |
| 01-Apr-24 5:01 PM View: | Bioatla, Inc. (BCAB) | 31-Mar-24 | Payment of Exercise | 2,181 | $3.44 | $7,502.64 | (< 1%) 294.64K to 292.45K | |
| 05-Mar-24 8:01 PM View: | Viatris Inc (VTRS) | 03-Mar-24 | Payment of Exercise | 55,377 | $12.59 | $697,196.00 | (39%) 140.73K to 85.35K | |
| 05-Mar-24 8:01 PM View: | Viatris Inc (VTRS) | 03-Mar-24 | Option Exercise | 140,727 | -- | -- | 100% 0 to 140.73K | |
| 01-Mar-24 4:22 PM View: | Bioatla, Inc. (BCAB) | 29-Feb-24 | Payment of Exercise | 2,181 | $2.70 | $5,888.70 | (< 1%) 296.82K to 294.64K | |
| 01-Feb-24 8:32 PM View: | Bioatla, Inc. (BCAB) | 31-Jan-24 | Payment of Exercise | 2,181 | $1.92 | $4,187.52 | (< 1%) 299.0K to 296.82K | |
| 03-Jan-24 8:17 PM View: | Bioatla, Inc. (BCAB) | 31-Dec-23 | Payment of Exercise | 1,791 | $2.46 | $4,405.86 | (< 1%) 300.79K to 299.0K | |
| 01-Dec-23 4:46 PM View: | Bioatla, Inc. (BCAB) | 30-Nov-23 | Payment of Exercise | 1,791 | $1.77 | $3,170.07 | (< 1%) 302.58K to 300.79K | |
| 01-Nov-23 9:17 PM View: | Bioatla, Inc. (BCAB) | 31-Oct-23 | Payment of Exercise | 1,791 | $1.47 | $2,632.77 | (< 1%) 304.37K to 302.58K | |
| 02-Oct-23 10:00 PM View: | Bioatla, Inc. (BCAB) | 30-Sep-23 | Payment of Exercise | 1,791 | $1.70 | $3,044.70 | (< 1%) 306.16K to 304.37K | |
| 01-Sep-23 8:03 PM View: | Bioatla, Inc. (BCAB) | 31-Aug-23 | Payment of Exercise | 1,791 | $2.51 | $4,495.41 | (< 1%) 307.95K to 306.16K | |
| 01-Aug-23 5:41 PM View: | Bioatla, Inc. (BCAB) | 31-Jul-23 | Payment of Exercise | 1,791 | $2.99 | $5,355.09 | (< 1%) 309.74K to 307.95K | |
| 03-Jul-23 5:43 PM View: | Bioatla, Inc. (BCAB) | 30-Jun-23 | Payment of Exercise | 1,791 | $3.00 | $5,373.00 | (< 1%) 311.54K to 309.74K | |
| 01-Jun-23 8:24 PM View: | Bioatla, Inc. (BCAB) | 31-May-23 | Payment of Exercise | 1,791 | $3.15 | $5,641.65 | (< 1%) 313.33K to 311.54K | |
| 02-May-23 10:00 PM View: | Bioatla, Inc. (BCAB) | 30-Apr-23 | Payment of Exercise | 1,791 | $3.37 | $6,035.67 | (< 1%) 315.12K to 313.33K | |
| 03-Apr-23 8:01 PM View: | Bioatla, Inc. (BCAB) | 31-Mar-23 | Payment of Exercise | 1,791 | $2.68 | $4,799.88 | (< 1%) 316.91K to 315.12K | |
| 01-Mar-23 6:33 PM View: | Bioatla, Inc. (BCAB) | 28-Feb-23 | Payment of Exercise | 1,791 | $2.98 | $5,337.18 | (< 1%) 318.7K to 316.91K | |
| 02-Feb-23 7:09 PM View: | Bioatla, Inc. (BCAB) | 31-Jan-23 | Payment of Exercise | 2,181 | $3.79 | $8,265.99 | (< 1%) 320.88K to 318.7K | |
| 03-Jan-23 5:07 PM View: | Bioatla, Inc. (BCAB) | 31-Dec-22 | Payment of Exercise | 1,791 | $8.25 | $14,775.80 | (< 1%) 322.67K to 320.88K | |
| 01-Dec-22 8:58 PM View: | Bioatla, Inc. (BCAB) | 30-Nov-22 | Payment of Exercise | 1,791 | $11.01 | $19,718.90 | (< 1%) 324.46K to 322.67K | |
| 01-Nov-22 7:54 PM View: | Bioatla, Inc. (BCAB) | 31-Oct-22 | Payment of Exercise | 1,791 | $6.89 | $12,340.00 | (< 1%) 326.25K to 324.46K | |
| 04-Oct-22 7:53 PM View: | Bioatla, Inc. (BCAB) | 30-Sep-22 | Payment of Exercise | 1,791 | $7.70 | $13,790.70 | (< 1%) 328.04K to 326.25K | |
| 01-Sep-22 6:47 PM View: | Bioatla, Inc. (BCAB) | 31-Aug-22 | Payment of Exercise | 1,791 | $8.71 | $15,599.60 | (< 1%) 329.83K to 328.04K | |
| 01-Aug-22 6:24 PM View: | Bioatla, Inc. (BCAB) | 31-Jul-22 | Payment of Exercise | 1,791 | $3.40 | $6,089.40 | (< 1%) 331.63K to 329.83K | |
| 01-Jul-22 5:23 PM View: | Bioatla, Inc. (BCAB) | 30-Jun-22 | Payment of Exercise | 1,791 | $2.85 | $5,104.35 | (< 1%) 333.42K to 331.63K | |
| 03-Jun-22 6:04 PM View: | Bioatla, Inc. (BCAB) | 31-May-22 | Payment of Exercise | 1,791 | $2.41 | $4,316.31 | (< 1%) 335.21K to 333.42K | |
| 06-May-22 4:58 PM View: | Bioatla, Inc. (BCAB) | 30-Apr-22 | Payment of Exercise | 1,791 | $3.48 | $6,232.68 | (< 1%) 337.0K to 335.21K | |
| 04-Apr-22 9:13 PM View: | Bioatla, Inc. (BCAB) | 31-Mar-22 | Payment of Exercise | 1,791 | $5.00 | $8,955.00 | (< 1%) 338.79K to 337.0K | |
| 04-Mar-22 5:03 PM View: | Bioatla, Inc. (BCAB) | 28-Feb-22 | Payment of Exercise | 1,791 | $6.48 | $11,605.70 | (< 1%) 340.58K to 338.79K | |
| 02-Feb-22 5:43 PM View: | Bioatla, Inc. (BCAB) | 31-Jan-22 | Payment of Exercise | 2,181 | $9.56 | $20,850.40 | (< 1%) 342.76K to 340.58K | |
| 05-Jan-22 8:33 PM View: | Bioatla, Inc. (BCAB) | 31-Dec-21 | Payment of Exercise | 2,894 | $19.63 | $56,809.20 | (< 1%) 345.66K to 342.76K | 4% |
| 07-Dec-21 5:41 PM View: | Bioatla, Inc. (BCAB) | 02-Dec-21 | Market Sale | 2,984 | $21.76 | $64,918.20 | (< 1%) 348.64K to 345.66K | (3%) |
| 07-Dec-21 5:41 PM View: | Bioatla, Inc. (BCAB) | 01-Dec-21 | Market Sale | 628 | $23.03 | $14,465.70 | (< 1%) 349.27K to 348.64K | 2% |
| 07-Dec-21 5:41 PM View: | Bioatla, Inc. (BCAB) | 30-Nov-21 | Market Sale | 478 | $24.51 | $11,715.40 | (< 1%) 349.75K to 349.27K | 8% |
| 06-Dec-21 8:42 PM View: | Bioatla, Inc. (BCAB) | 29-Nov-21 | Market Sale | 399 | $23.89 | $9,532.11 | (< 1%) 350.14K to 349.75K | 6% |
| 30-Nov-21 8:06 PM View: | Bioatla, Inc. (BCAB) | 24-Nov-21 | Market Sale | 466 | $24.87 | $11,588.60 | (< 1%) 350.61K to 350.14K | 4% |
| 30-Nov-21 8:06 PM View: | Bioatla, Inc. (BCAB) | 23-Nov-21 | Market Sale | 684 | $24.92 | $17,046.70 | (< 1%) 351.3K to 350.61K | 4% |
| 30-Nov-21 8:06 PM View: | Bioatla, Inc. (BCAB) | 22-Nov-21 | Market Sale | 430 | $26.24 | $11,281.00 | (< 1%) 351.73K to 351.3K | 9% |
| 07-Oct-21 6:09 PM View: | Bioatla, Inc. (BCAB) | 01-Oct-21 | Market Sale | 2,994 | $30.18 | $90,351.40 | (< 1%) 354.72K to 351.73K | 6% |
| 30-Aug-21 9:43 PM View: | Bioatla, Inc. (BCAB) | 26-Aug-21 | Market Sale | 33,244 | $40.16 | $1,334,930.00 | (9%) 387.96K to 354.72K | (2%) |
| 16-Jun-21 9:25 PM View: | Bioatla, Inc. (BCAB) | 14-Jun-21 | Acquisition (other) | 34,963 | -- | -- | 10% 353.0K to 387.96K | |
| 02-Jan-20 5:17 PM View: | F-Star Therapeutics, Inc. (FSTX) | 31-Dec-19 | Grant | 12,500 | -- | -- | 50% 24.98K to 37.48K | |
| 01-Oct-19 4:49 PM View: | F-Star Therapeutics, Inc. (FSTX) | 30-Sep-19 | Grant | 5,741 | -- | -- | 30% 19.23K to 24.98K | |
| 01-Jul-19 9:04 AM View: | F-Star Therapeutics, Inc. (FSTX) | 28-Jun-19 | Grant | 5,352 | -- | -- | 39% 13.88K to 19.23K | |
| 28-Jun-19 3:25 PM View: | F-Star Therapeutics, Inc. (FSTX) | 28-Jun-19 | Market Purchase | 12,000 | $4.09 | $49,080.00 | 637% 1.88K to 13.88K | (37%) |
| 02-Apr-19 4:05 PM View: | F-Star Therapeutics, Inc. (FSTX) | 29-Mar-19 | Grant | 1,883 | -- | -- | 100% 0 to 1.88K | |
| 20-Feb-18 5:03 PM View: | Celgene Corporation (CELG) | 17-Feb-18 | Payment of Exercise | 2,329 | $95.26 | $221,861.00 | (4%) 54.54K to 52.21K | 5% |
| 20-Feb-18 5:03 PM View: | Celgene Corporation (CELG) | 17-Feb-18 | Option Exercise | 7,283 | -- | -- | 15% 47.25K to 54.54K | |
| 20-Dec-17 4:05 PM View: | Celgene Corporation (CELG) | 19-Dec-17 | Payment of Exercise | 1,768 | $107.06 | $189,282.00 | (4%) 49.02K to 47.25K | 15% |
| 20-Dec-17 4:05 PM View: | Celgene Corporation (CELG) | 19-Dec-17 | Option Exercise | 3,410 | -- | -- | 7% 45.61K to 49.02K |